In Simple Terms
Scientists have found that a protein called PD-L2 helps damaged cells, which appear as we age, to hide from the immune system. This allows them to build up and cause health problems. If researchers can stop this protein, it might improve health as we get older.
The Role of PD-L2 in Aging Cells
Researchers at Cedars-Sinai Medical Center have discovered that the protein PD-L2 helps aging cells avoid detection by the immune system. These aging cells stop dividing but don’t die, accumulating in tissues and releasing harmful substances that affect nearby cells.
PD-L2’s Function in Senescent Cells
PD-L2 is known for its role in immune checkpoint signaling, often used by cancer cells to evade the immune system. The new study explored whether this mechanism allows aging cells to escape immune surveillance as we age.
Findings showed that PD-L2 levels increase in isolated aging human cells and rise with age in certain tissues. Soluble PD-L2 levels in the blood also increase with age but decrease after treatment with senolytics.
Mouse Experiments
Researchers tested the effects of removing or blocking PD-L2 in mice. Older mice lacking PD-L2 showed fewer aging cells compared to normal mice. These mice also had better insulin sensitivity and grip strength, indicators of metabolic function and physical fitness.
In normal aging mice, anti-PD-L2 treatment restored insulin sensitivity and increased physical strength, suggesting this protein may help aging cells avoid removal, promoting their persistence as we age.
Future Prospects
The study suggests targeting PD-L2 could be a promising strategy to reduce the burden of aging cells. If scientists can develop safe and effective ways to block this protein, it might improve overall health and address many age-related health issues.
However, researchers caution that more studies are needed to determine if blocking PD-L2 can safely provide health benefits in humans.
Conclusion
This study highlights the role of PD-L2 in protecting aging cells from immune detection, allowing them to accumulate and contribute to age-related health problems. Targeting this protein opens new possibilities for combating aging effects and improving quality of life. The biggest challenge remains ensuring the safety and effectiveness of these treatments in humans.